SHANGHAI HI SILICON TECHNOLOGY CO., LTD.
SHANGHAI HI SILICON TECHNOLOGY CO., LTD.

Rh(acac)₃: Major Process Improvements & Breakthroughs of High Market Share Brands in China and Globally

Table of Content [Hide]

    As a new type of foreign trade service provider driven by both technology transformation and foreign trade services, HiSiaddi has established a "1+2+3+4=1" service system and can supply Rh(acac)₃ from multiple well-known original manufacturers.

    As a foreign trade enterprise with R&D capabilities, HiSiaddi is not limited to self-promotion like single-brand factories. We objectively analyze multiple high-market-share renowned domestic and global brands and share their major process advances and breakthroughs, enabling buyers to access authentic, timely, and valuable market information.

    For more comprehensive and valuable Rh(acac)₃ market information, please contact HiSiaddi customer service.

    I. Core Technological Breakthroughs of China’s Top 5 Export Brands (Sino-Platinum Metals, Xi’an Kaili, Shaanxi Ruike, Jiangsu Jinwo, GRINM Advanced Materials, 2025–2026 Process & Indicator Upgrades)

    (I) Innovative Synthetic Raw Material Path Breakthrough: Industrialized Mass Production of Rh(IV) In-Situ Hydrolysis Process

    Sino-Platinum Metals, in collaboration with Yunnan Precious Metals Laboratory, completed industrialization of an innovative synthetic process that abandons the traditional trivalent rhodium salt feedstock route. Rhodium tetrachlorate is adopted as raw material with a CO₂ buffered acidification system to synthesize Rh(acac)₃, eliminating chloride, nitrate, and sulfur impurity introduction throughout the process and avoiding the generation of chloride-coordinated heterosalt by-products.

    1. Product indicator improvements Purity of electronic-grade high-purity products increased from the original 99.3% to 99.95%, with measured rhodium content stabilized at 25.80%±0.03% and heavy metal impurities <5ppm, meeting semiconductor CVD coating precursor access standards. Overall product yield rose from 88% to 93.7%.

    2. Buyer benefits ① Downstream pharmaceutical CDMO and electronic material manufacturers eliminate secondary refining rectification processes, cutting raw material pre-treatment costs by 18%; ② Batch-to-batch impurity fluctuation range narrowed from ±0.25% to ±0.04%, removing the need for frequent catalytic process parameter adjustments and boosting production line continuous operating rates.

    (II) Precision Sublimation Purification Technical Renovation Breakthrough: Full-Coverage Mass Production of Graded Specifications

    Xi’an Kaili completed continuous vacuum gradient sublimation production line upgrades in 2025, enabling standardized mass production of three grades: industrial grade (99.0%), pharmaceutical grade (99.5%), and semiconductor grade (99.95%) via optimized segmented heating-pressure control purification parameters.

    1. Product indicator improvements Free acetylacetone residue in pharmaceutical-grade products reduced from 320ppm to <45ppm, with chiral catalytic selectivity fluctuation narrowed from ±2.1% to ±0.5%. Thermal decomposition stability improved, with rhodium precipitation loss ≤0.12% after 24h heat preservation at 275°C (down from the original 0.78%).

    2. Buyer benefits ① Overall impurity levels of chiral API hydrogenation reaction products for overseas pharmaceutical manufacturers decreased by 35%, with average target intermediate yield improved by 7%~9%; ② Precise grade selection and stocking aligned with downstream segmented scenarios eliminates premium cost waste for high-purity raw materials, cutting inventory stocking costs for small and medium buyers.

    (III) Modified Coordination Optimization Breakthrough: Custom Low-Activation-Energy Products Launched

    Shaanxi Ruike developed micro-modified ligand technology introducing trace alkyl side chains into acetylacetone coordination structures to launch specialized catalytic Rh(acac)₃ products tailored to two scenarios: long-chain olefin hydroformylation and isothiocyanate pharmaceutical intermediate synthesis.

    1. Product indicator improvements Catalytic reaction activation temperature reduced from 85°C to 52~68°C at identical dosing volumes, catalytic turnover number (TON) increased by 42%, and single-cycle catalyst service life extended by over 30%.

    2. Buyer benefits ① Steam energy consumption of reaction kettles for overseas fine chemical manufacturers reduced by 27%, eliminating high-pressure reaction equipment modification investments; ② Waste rhodium catalyst generation decreased, lowering precious metal recycling expenses.

    (IV) Rhodium Atom Utilization Breakthrough: Closed-Loop Mother Liquor Recovery Process Launched

    Jiangsu Jinwo optimized a closed-loop crystallization mother liquor circulation system paired with membrane separation rhodium enrichment technology, lifting total rhodium production recovery from 91.2% to 98.6% and drastically cutting unit rhodium raw material loss during mass production.

    1. Product indicator improvements Ex-factory unit price of identical-grade products reduced by 7.2% year-on-year vs. 2024, with unified batch color, uniform crystal morphology across all batches, and 20% faster dissolution rate in organic solvents.

    2. Buyer benefits Stable spot quotation performance with extended price adjustment lag periods amid rhodium price volatility, enabling overseas buyers to lock long-term contract costs more easily.

    (V) National Standard Benchmark Quality Breakthrough: Upgraded Internal Controls Aligned with European & American Pharmacopoeia Standards

    Drawing on R&D data from national standard formulation for Rhodium Dicarbonyl Acetylacetonate, GRINM Advanced Materials upgraded internal Rh(acac)₃ testing systems, adding two mandatory factory inspection items: ICP-MS full elemental screening and HPLC organic impurity analysis.

    1. Product indicator improvements All product categories meet USP/EP pharmacopoeia impurity control limits, with batch test reports directly usable for import filing by European and American pharmaceutical manufacturers. Non-conforming factory output rate dropped from 0.85% to 0.11%.

    2. Buyer benefits 100% inspection pass rate for overseas import customs pharmaceutical sampling, shortening customs clearance cycles by 3–7 working days and avoiding port sampling detention and warehousing costs.

    II. Technological Breakthroughs of the World’s Top 5 Foreign Brands by Market Share (Johnson Matthey, Umicore, Strem, American Elements, ABCR, 2025–2026 Improvement Directions)

    (I) Nano Precursor Modification Breakthrough: Mass Production of Ultra-Fine Crystal Products for Carrier Loading (Johnson Matthey)

    Johnson Matthey developed spray crystallization manufacturing technology to launch ultra-fine powder Rh(acac)₃ dedicated to carrier impregnation for supported rhodium catalyst preparation.

    1. Product indicator improvements Average product particle size of 3.2μm (vs. conventional 15–30μm), 55% improved uniform dispersion on silica and alumina carriers, and enhanced compactness of CVD-deposited thin films.

    2. End-user benefits Raw material dosing reduced by 12% for manufacturers producing rhodium-based catalytic coatings, with thin film pinhole defect rates cut by 48%.

    (II) Low Residual Solvent Process Breakthrough: Mass Production of Halogen-Free Eco-Friendly Grade (Umicore)

    Umicore replaced halogenated extraction solvents such as dichloromethane across full production workflows to launch REACH-compliant eco-friendly Rh(acac)₃ for the EU market.

    1. Product indicator improvements Halogen solvent residues <1ppm, complying with new EU chemical control legislation and enabling direct use in food additive catalytic synthesis.

    2. Buyer benefits EU-region buyers eliminate additional solvent residual compliance testing and associated compliance surcharges.

    (III) Pre-Mixed Compound Product Breakthrough: Integrated Ligand Pre-Blended Products (Strem)

    Strem industrialized pre-mixed packaging processes combining Rh(acac)₃ with specialized organophosphine ligands, launching ready-to-feed compound raw materials for hydroformylation reactions.

    1. Product indicator improvements On-site ratio error controlled from ±3% to ±0.3%, enabling direct feeding upon container opening without in-house compounding by buyers.

    2. Buyer benefits Eliminates labor and metering equipment investment for raw material ratio preparation, boosting small-batch R&D procurement efficiency by 60%.

    (IV) Ultra-High-Purity Mass Production Breakthrough: Stable Mass Production of 99.99% Laboratory Grade (American Elements)

    American Elements adopted zone melting secondary purification technology to achieve stable mass production of 4N ultra-high-purity Rh(acac)₃ for university research and cutting-edge fuel cell precursor R&D.

    1. Product indicator improvements Single metallic impurities <10ppb, oxygen and nitrogen non-metallic impurities <20ppb.

    2. Buyer benefits Research institutions and new energy startups eliminate multi-batch raw material splitting and re-purification workflows, delivering drastically improved experimental data repeatability.

    (V) Moisture-Proof Packaging Matching Breakthrough: Optimized Long-Term Oxygen-Barrier Packaging (ABCR)

    ABCR upgraded double-layer packaging consisting of aluminum foil vacuum bags filled with inert nitrogen gas, resolving long-term storage micro-oxidation deterioration pain points of Rh(acac)₃.

    1. Product indicator improvements Purity decline ≤0.08% after 18 months of ambient storage (vs. original 0.35% purity drop after only 6 months).

    2. Buyer benefits Mass quarterly stocking becomes feasible with drastically reduced losses during long-distance ocean shipping and bonded warehousing, cutting high-frequency small-batch ocean freight expenses.

    III. Summary of Common Benefits Delivered to Global Downstream Buyers & End Customers by All Category Technological Breakthroughs

    1. Cost side: Combined domestic leading manufacturer process rhodium loss reduction and overseas brand formula optimization drove a 5%~9% year-on-year decline in global procurement prices for identical specifications. Raw material unit consumption dropped by 7%~15% across three major sectors: pharmaceuticals, fine chemicals, and electronics, delivering synchronized production cost reductions.

    2. Production side: Upgraded catalytic selectivity and stability cut reaction by-products, lowering three-waste treatment costs by 22%~30% to align with new global environmental emission limit regulations.

    3. Compliance side: Domestic and international products simultaneously benchmark European and American pharmacopoeia, REACH, and semiconductor material access standards, removing raw material compliance barriers for buyers exporting end products across multiple regions.

    4. Stocking side: Mass production of multiple graded specifications paired with long-term storage technology enables flexible multi-grade procurement to optimize inventory structures and reduce capital occupation.

    For more comprehensive and valuable Rh(acac)₃ market information, please contact HiSiaddi customer service.


    References
    We use cookies to optimise and personalise your experience, but you can choose to opt out of non-essential cookies.
    To find out more, read our Privacy Policy
    Reject All
    Accept All